Renin-angiotensin and kallikrein-kinin systems: a significance in the benign prostatic hyperplasia pathogenesis
Open Access
- 16 July 2019
- journal article
- Published by Rostov State Medical University in Urology Herald
- Vol. 7 (2)
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysisJournal of International Medical Research, 2013
- Fat boosts, while androgen receptor activation counteracts, BPH‐associated prostate inflammationThe Prostate, 2012
- CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic FibrosisPLOS ONE, 2012
- Lower Urinary Tract Symptoms Revisited: A Broader Clinical PerspectiveEuropean Urology, 2008
- Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancerJournal of Laboratory and Clinical Medicine, 2006
- International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological ConsequencesPharmacological Reviews, 2005
- Pharmacological and functional characterization of bradykinin B2 receptor in human prostateEuropean Journal of Pharmacology, 2004
- Evidence for activation of the renin–angiotensin system in the human prostate: increased angiotensin II and reduced AT1 receptor expression in benign prostatic hyperplasiaThe Journal of Pathology, 2001
- Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasiaJournal of Endocrinology, 2001
- Characterization and determination of the complex between prostate-specific antigen and α1-protease inhibitor in benign and malignant prostatic diseasesScandinavian Journal of Clinical and Laboratory Investigation, 2000